aod9604 development discontinued A0D9604 – Essentialpeptideusa Produced using quality AOD-9604 | Next Gen Peptides

Reasonable markers to track: waist circumference, weight, resting heart rate, sleep quality, and a basic liver panel (ALT, AST) before and after long cycles

In the context of body composition interventions, selectivity is particularly valuable because many metabolic processes are interconnected

It is not yet FDA-approved (still in Phase 3 trials as of February 2026), so it is only available through research suppliers

Weeks 1-4: Foundation Phase The first four weeks establish whether you respond to AOD-9604 and whether the protocol suits your body

This process improves blood pressure and cholesterol levels, which lower heart disease risk

AOD-9604 is best suited to adults who have a healthy relationship with food and training but cannot shift the last 5-15% of body fat